# Trade Mark Journal No.2025/048 28 November 2025

## UK00004297321 19 November 2025 (5,10,42,44)

Class 5
  Pharmaceutical products, nutraceuticals, vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions; pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum; medicated cannabinoids.
Class 10
  Medical devices; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers; dry powder inhalers (DPI); nebulizers; pressurized metered-dose inhalers (pMDI).
Class 42
  Medical research services; scientific research services; pharmaceutical development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems.
Class 44
  Medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems.

Aspeya Switzerland SA

Representative: CMS Cameron McKenna Nabarro Olswang LLP